ʳ¹ÜÖ×Áö/·ÅÉäÁÆ·¨,Esophageal neoplasms/radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÐØÜÕÁ×Ëữø,Thymidine phosphorylaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ȫֱ³¦ÏµÄ¤ÇгýÊõ,Total mesorectal excisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔ¸Îϸ°û°©,Primary hepatocellular carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÖ×Áö/²¡Àíѧ,liver neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼äÖÊÁö,Stromal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ïû»¯ÏµÍ³Ö×Áö,digestive system neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹ÜÖ×Áö/Ò©ÎïÁÆ·¨,esophageal neoplasms/drug therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áÖ±³¦Ö×Áö/²¡Àíѧ,colorectal neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ǰÉÚÁܰͽá»î×éÖ¯¼ì²é,Sentinel lymph node biopsyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÓºÏ×Ó¶ªÊ§,Loss of heterozygosityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
CT¹à×¢³ÉÏñ,CT perfusion imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θÖ×Áö/²¡Àíѧ,stomach neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×Ôɱ»ùÒòÖÎÁÆ,Suicide gene therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ê®¶þÖ¸³¦Ö×Áö,duodenal neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µÍÉø,low permeabilityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
賦µÀ¼äÖÊÖ×Áö,Gastrointestinal stromal tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
cyclinE,Cyclin EÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ȫֱ³¦ÏµÄ¤Çгý,total mesorectal excisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½þÈó×ªÒÆ,Invasion and metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ѫ¹ÜÇòÁö,glomus tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
±½¶¡ËáÄÆ,sodium phenylbutyrateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´ó³¦ÏÙ°©,colorectal adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñªß²ßøÑÜÉúÎï,Hematoporphyrin derivativeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²ãÕ³Á¬µ°°×ÊÜÌå,laminin receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ÄÚ·ÖÃÚ°©,neuroendocrine carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÖ×Áö/¼Ì·¢ÐÔ,Liver Neoplasms/secondaryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹ÜÖ×Áö/»¯Ñ§ÁÆ·¨,Esophageal neoplasms/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Õýµç×Ó·¢Éä¶Ï²ã,Positron emission tomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÂÕæÄÚ¾µ,Virtual endoscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êõǰ»¯ÁÆ,Preoperative chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙÖ×Áö/²¡Àíѧ,pancreatic neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤ºóÖ×Áö,Retroperitoneal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
DNAÖ¸Êý,DNA indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·ÅÉäÖ×Áöѧ,Radiation oncologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰͽáÇåɨ,lymphadenectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²Ðθ°©,gastric stump carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
E1A»ùÒò,E1A geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ô·¢ÐÔ¸¹Ä¤ºóÖ×Áö,primary retroperitoneal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ò¸ÎÑÁܰͽá,axillary lymph nodeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʾ×Ù¼¼Êõ,tracer techniqueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁÛ°©,squamous cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶þÏ©±û»ùÈýÁò,diallyl trisulfideÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ä¤×ªÒÆ,Peritoneal metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´Òå»ùÒòÖÎÁÆ,antisense gene therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´¿ºÏÐÔȱʧ,Homozygous deletionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸»ÎøÂóÑ¿,selenium-enriched maltÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´íÅäÐÞ¸´»ùÒò,Mismatch repair geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸Îº£Ãà״Ѫ¹ÜÁö,hepatic cavernous hemangiomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θÖ×Áö/ÒÅ´«Ñ§,stomach neoplasms/geneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÈÏÙÖ×Áö/·ÅÉäÁÆ·¨,pancreatic neoplasms/radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
и¨ÖúÖÎÁÆ,Neoadjuvant therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸¹Ç»ÄÚ»¯ÁÆ,Intraperitoneal chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÄÚµ¨¹Ü°©,Intrahepatic cholangiocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
NGX6»ùÒò,NGX6 geneÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰͽáÎ¢×ªÒÆ,lymph node micrometastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¼¤ËØÊÜÌå,hormone receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
EC9706ϸ°û,EC9706 cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËÌå×é³É,Body compositionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʾ·¶»ùµØ,demonstration baseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾½þÈó,Perineural invasionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θÖ×Áö/»¯Ñ§ÁÆ·¨,Stomach neoplasms/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áÖ±³¦Ö×Áö/Ò©ÎïÁÆ·¨,colorectal neoplasms/drug therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ö×Áö¸¨ÖúÁÆ·¨,Neoadjuvant TherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
½áÖ±³¦Ö×Áö/»¯Ñ§ÁÆ·¨,Colorectal neoplasms/chemotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
²àÏò·¢ÓýÐÍÖ×Áö,Laterally spreading tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢²¨¹Ì»¯,microwave coagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ì«ÐÐÉ½Çø,Taihang mountain areaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
΢²¨Äý¹Ì,Microwave coagulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÒÅ´«ÐÔ·ÇÏ¢ÈⲡÐÔ½áÖ±³¦°©,Hereditary nonpolyposis colorectal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÉöÖ×Áö/²¡Àíѧ,kidney neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ϸ°ûÖ§¼Üµ°°×ÖÊÀà,cytoskeletal proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈËÀàÈéÍ·×´Áö²¡¶¾,Human papillomavirusÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
»·¾³Î£ÏÕÒòËØ,environmental risk factorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÇÖÏ®Óë×ªÒÆ,Invasion and metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Êõǰ·ÅÁÆ,Preoperative radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÁܰͿ×,lymphatic stomataÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´ÒåÖÎÁÆ,antisense therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶þÁÑÒøÐÓ,Ginkgo bilobaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¶ñÐÔµ¨µÀ¹£×è,Malignant biliary obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
µ°°×ÖÊP21,protein P21Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ñ¡ÔñÐÔ¼ôÇÐ,alternative splicingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
θÖ×Áö/Á÷Ðв¡Ñ§,stomach neoplasms/epidemiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÈÈÐݿ˵°°×Àà,Heat shock proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¸ÎÖ×Áö/ÃâÒßѧ,liver neoplasms/immunologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ïٹܿª¿Ú,pit patternÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
·´Ïò´«²¥Éñ¾ÍøÂç,BP neural networkÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÂÌÉ«Êß²Ë,green vegetableÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
M´øÐ¡²¨±ä»»,M-band wavelet transformÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Ki67µ°°×,Ki67 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ǰÇгýÊõ,anterior resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ÔÓºÏȱʧ,loss of heterozygosityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
HepG2ϸ°ûϵ,HepG2 cell lineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
Éñ¾ÇÖÏ®,Neural invasionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
пָ,Zinc fingerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
´Å°ÐÏò,magnetic targetingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
PET,poly(ethylene terephthalate)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ«
¹£×èÐԻƾÒ,Obstructive jaundiceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
ʳ¹ÜÖ×Áö/ÒÅ´«Ñ§,esophageal neoplasms/geneticsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«
×ªÒÆÐÔ½áÖ±³¦°©,Metastatic colorectal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«

|